Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trialsNish Chaturvedi, Anne Katrin Sjølie, Massimo Porta et al.|The Lancet|2008Cited by 450
Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trialAnne Katrin Sjølie, Nish Chaturvedi, Ronald Klein et al.|The Lancet|2008Cited by 432
Relationship Between Risk Factors and Mortality in Type 1 Diabetic Patients in EuropeSabita S. Soedamah‐Muthu, Nish Chaturvedi, Daniel R. Witte et al.|Diabetes Care|2008Cited by 233
Diabetic Retinopathy Is Associated With Mortality and Cardiovascular Disease IncidenceManon V. van Hecke, Nish Chaturvedi, R. Rottiers et al.|Diabetes Care|2005Cited by 180